<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Preevnts on Bioecon</title><link>https://en.bioecon.ru/companies/preevnts/</link><description>Recent content in Preevnts on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 20 Jul 2026 20:17:07 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/preevnts/index.xml" rel="self" type="application/rss+xml"/><item><title>Exhaled-breath glucose monitoring</title><link>https://en.bioecon.ru/technology/exhaled-breath-glucose-monitoring/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/exhaled-breath-glucose-monitoring/</guid><description>Non-invasive breath-analyte devices aiming to monitor diabetes-relevant metabolic state without a fingerstick or implanted sensor — most commercially advanced platforms detect breath acetone/ketones as a metabolic proxy, while newer entrants target a more direct blood-glucose alert claim: PranaQ, Invoy Technologies, LEVL and PREEVNT, all US-based.</description></item></channel></rss>